ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AUPH Aurinia Pharmaceuticals Inc

4.99
-0.01 (-0.20%)
Last Updated: 12:16:42
Delayed by 15 minutes

Period:

Draw Mode:

Volume 557,284
Bid Price 4.99
Ask Price 5.00
News -
Day High 5.04

Low
4.85

52 Week Range

High
12.43

Day Low 4.97
Share Name Share Symbol Market Stock Type
Aurinia Pharmaceuticals Inc AUPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.20% 4.99 12:16:42
Open Price Low Price High Price Close Price Previous Close
4.99 4.97 5.04 5.00
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,111 557,284 US$ 5.01 US$ 2,791,683 - 4.85 - 12.43
Last Trade Type Quantity Price Currency
12:17:42 300 US$ 4.99 USD

Aurinia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
721.64M 144.62M - 175.51M -78.02M -0.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aurinia Pharmaceuticals News

Date Time Source News Article
3/07/202415:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:10Edgar (US Regulatory)Form 8-K - Current report
2/29/202407:30Business WireAurinia Receives Exemptive Relief from Canadian Securities..
2/27/202407:30Business WireAurinia to Participate in Upcoming Investor Healthcare..
2/22/202415:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AUPH Message Board. Create One! See More Posts on AUPH Message Board See More Message Board Posts

Historical AUPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.205.254.854.981,403,685-0.21-4.04%
1 Month5.966.024.855.301,600,005-0.97-16.28%
3 Months8.469.434.856.722,468,690-3.47-41.02%
6 Months7.9910.054.857.492,194,029-3.00-37.55%
1 Year10.7212.434.858.982,293,256-5.73-53.45%
3 Years12.4533.97154.0712.582,948,123-7.46-59.92%
5 Years6.4533.97153.5213.042,499,874-1.46-22.64%

Aurinia Pharmaceuticals Description

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Your Recent History

Delayed Upgrade Clock